Clinical trials
Phase 2 Carcinoma, Non-Small-Cell Lung trials in Austria
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
29 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2005 | 2 |
| 2006 | 1 |
| 2007 | 1 |
| 2009 | 1 |
| 2010 | 1 |
| 2014 | 1 |
| 2015 | 4 |
| 2016 | 1 |
| 2017 | 2 |
| 2018 | 1 |
| 2019 | 1 |
| 2020 | 1 |
| 2021 | 4 |
| 2023 | 1 |
| 2024 | 2 |
| 2025 | 2 |
| 2026 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 15 |
| Active, not recruiting | 4 |
| Terminated | 4 |
| Recruiting | 2 |
| Withdrawn | 2 |
| Unknown status | 1 |
| Not yet recruiting | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| AstraZeneca | 3 |
| European Organisation for Research and Treatment of Cancer - EORTC | 3 |
| Bristol-Myers Squibb | 2 |
| Eli Lilly and Company | 2 |
| Novartis Pharmaceuticals | 2 |
| Advanced Accelerator Applications | 1 |
| Amgen | 1 |
| Arbeitsgemeinschaft medikamentoese Tumortherapie | 1 |
| BeiGene | 1 |
| Central European Cooperative Oncology Group | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Carcinoma, Non-Small-Cell Lung | 29 |
| Lung Neoplasms | 6 |
| Melanoma | 4 |
| Neoplasm Metastasis | 4 |
| Brain Neoplasms | 2 |
| Breast Neoplasms | 2 |
| Carcinoma, Renal Cell | 2 |
| Neoplasms | 2 |
| Pancreatic Neoplasms | 2 |
| Adenocarcinoma | 1 |
Trials
Showing 1 to 25 of 29. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.